Researchers have made a discovery that may serve as a basis for treatment of the amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease. Reduced levels of the microRNA miR-126-5 were linked to toxicity in patients with Lou Gehrig’s disease. Manipulating the molecule can improve ALS symptoms and slow down the neuron degeneration process. ALS The neurodegenerative disease...